For a span of several months, 22-year-old college attendee Breeze Hunter was plagued by an unrelenting throb within her head—an ache she chalked up to stubborn sinus congestion. 

“I felt constant pressure and discomfort behind my ears,” she recounted. “The clinic visits led to one conclusion—just a pesky sinus infection.”

But as days passed and her strength waned so greatly she couldn’t manage the short trek to lectures, a blood draw was suggested. The results? Immediate hospitalization was not a recommendation—it was imperative, according to today.com.

“I was in disbelief—shocked. It felt like my thoughts vanished into static,” she remembered. “I just couldn’t grasp the words—leukemia?”

An Unseen Monster Behind a Familiar Mask

Though the congestion in her nasal passages was nagging, Breeze never imagined it masked something far more sinister. Even when fatigue grew heavy, and climbing stairs turned impossible, she assumed the worst was over.

In an autumn check-up in 2024, she finally voiced her full symptoms.

“I said the headaches never left, and now I could barely function,” she said. “They pushed for a blood test.”

Despite a fear of needles, she complied. Once the results came in, the clinic staff’s faces revealed more than their words.

“They told me my blood levels were chaos—dangerous. That I was severely anemic,” she recalled.

Thinking she only needed iron supplements, she was ready to hit the pharmacy. But the urgency in their eyes told another story.

“They were like, ‘No, iron won’t fix this,’” she said.

The campus hospital was too full to admit her, so she drove back to League City. After a quick online search of her results, she turned to her mother with a guess.

“I told her I thought I had leukemia,” Hunter said. “She said not to jump to conclusions.”

However, upon arrival at a nearby ER, several tests were ordered quickly. Medical professionals tiptoed around the word, offering vague possibilities, but one phrase began to echo louder.

Confirmed Fear, Uncertain Road

By dawn, a physician from MD Anderson Cancer Center confirmed the suspicion.

“I unraveled,” she said. “I didn’t even know what leukemia truly was. Could I survive? Was it terminal?”

Transferred to MD Anderson in Houston, more diagnostics ensued—blood analyses, a spinal puncture, and bone marrow extraction. The verdict: high-risk acute myeloid leukemia (AML), as per today.com.

She remained hospitalized, commencing a grueling weeklong chemotherapy course, accompanied by a clinical trial pill. After 21 days, her marrow was re-tested. The protocol was repeated.

“Initially, they planned for six chemo rounds,” Hunter said. “But I responded so incredibly well—I only needed two.”

The Healing Fire and the Cost of Survival

Doctors soon determined that her best hope was a stem cell transplant. Her younger brother Roy, 21, proved a genetic match. Before the procedure, she endured 11 sessions of radiation to eradicate rogue cancer cells, followed by yet another fierce chemo onslaught.

“I got scorched from the inside out—literal radiation burns covered me,” she shared. “That chemo? It made the first one feel mild.”

Post-transplant, her stay was extended for over a month to shield her compromised immune defenses.

“By the end, I was mentally depleted,” she said. “But my faith carried me—I felt protected.”

What AML Really Is

Acute myeloid leukemia is a ferocious blood malignancy, striking at the marrow of life—white blood cells. Dr. Courtney DiNardo, a leukemia expert at MD Anderson, explained that this cancer often shows up uninvited through bizarre infections or blood anomalies, according to today.com.

“It’s a loss of your normal defense system,” she said. “The immune cells turn rogue, leaving you defenseless.”

For many, symptoms resist normal treatments, and only further tests unveil the hidden adversary.

Hunter’s clinical trial—specifically targeted at KMT2A-translocated AML—used a chemotherapy regimen named FLAG-IDA along with a pill called venetoclax. Though venetoclax is FDA-approved for older patients unable to handle intense chemo, this trial pushed its limits.

“It’s not yet an FDA-approved combination, but the outcomes have been remarkable,” DiNardo noted. “We’re enrolling more to offer hope.”

Spirit Unshaken, Light Rekindled

Despite everything, Hunter emerged stronger. Her treatment response stunned even the doctors.

“She’s thriving,” DiNardo said. “To be so young and hit with a life-altering illness—and still radiate light—it’s awe-inspiring.”

While hospitalized, Hunter filmed a playful TikTok spoofing an MTV “Cribs” tour of her room. It exploded online.

“It was a lighthearted thing that turned into something huge,” she smiled, according to today.com.

The platform connected her to others, including a 6-year-old girl, Zoe, who is also battling AML.

“She’s endured so much, and she’s only six,” Hunter said. “Her strength lifts me up.”

Now, with her immune system on the mend, Hunter prepares to walk across the graduation stage—her first real crowd in ages.

“I’m beyond thrilled,” she beamed.

Though maintenance chemo remains in her life for another year, her spirit is vibrant and eager for life—ready for lake days and sunshine.

“Cancer is terrifying,” she concluded. “If you notice anything off—headaches, odd bruises, fatigue—don’t brush it off. Get checked. Bloodwork could change everything.”